NCT06832878View on ClinicalTrials.gov

Postoperative Oral Tranexamic Acid in Patients Undergoing Primary Total Joint Arthroplasty

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

101

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Arthroplasty

Interventions

DRUG

Oral Tranexamic Acid

Subjects will receive a 1.95 g dose of oral TXA at the following timepoints: (1) following ambulation, (2) postoperative day 1, (3) postoperative day 2, and (4) postoperative day 3

Trial Locations (1)

85259

Mayo Clinic in Arizona, Scottsdale